ATE210677T1 - Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung - Google Patents
Die verwendung von angiotensin iii und seiner analoge für die gewebeheilungInfo
- Publication number
- ATE210677T1 ATE210677T1 AT94928150T AT94928150T ATE210677T1 AT E210677 T1 ATE210677 T1 AT E210677T1 AT 94928150 T AT94928150 T AT 94928150T AT 94928150 T AT94928150 T AT 94928150T AT E210677 T1 ATE210677 T1 AT E210677T1
- Authority
- AT
- Austria
- Prior art keywords
- analogues
- angiotensin iii
- tissue healing
- wound healing
- analogs
- Prior art date
Links
- QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 title abstract 2
- 101800000738 Angiotensin-3 Proteins 0.000 title abstract 2
- 102400000348 Angiotensin-3 Human genes 0.000 title abstract 2
- 230000035876 healing Effects 0.000 title 1
- 230000029663 wound healing Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12636893A | 1993-09-24 | 1993-09-24 | |
| PCT/US1994/010503 WO1995008337A1 (en) | 1993-09-24 | 1994-09-19 | Use of angiotensin iii and analogs thereof in tissue repair |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE210677T1 true ATE210677T1 (de) | 2001-12-15 |
Family
ID=22424455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94928150T ATE210677T1 (de) | 1993-09-24 | 1994-09-19 | Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5629292A (de) |
| EP (1) | EP0730465B1 (de) |
| JP (1) | JPH09502977A (de) |
| AT (1) | ATE210677T1 (de) |
| AU (1) | AU706333B2 (de) |
| CA (1) | CA2172493C (de) |
| DE (1) | DE69429450T2 (de) |
| DK (1) | DK0730465T3 (de) |
| ES (1) | ES2168312T3 (de) |
| PT (1) | PT730465E (de) |
| TW (1) | TW311088B (de) |
| WO (1) | WO1995008337A1 (de) |
| ZA (1) | ZA947338B (de) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955430A (en) * | 1993-09-24 | 1999-09-21 | University Of Southern California | Use of angiotensin II fragments and analogs thereof in tissue repair |
| AU758319B2 (en) * | 1994-11-14 | 2003-03-20 | University Of Southern California | Use of angiotensin II fragments and analogs thereof in tissue repair |
| US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
| US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| MY121607A (en) * | 1995-07-10 | 2006-02-28 | Hyundai Curitel Inc | Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof |
| US6110895A (en) * | 1996-12-16 | 2000-08-29 | University Of Southern California | Method of promoting healing in skin grafts |
| US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| EP1410801B1 (de) | 1997-01-28 | 2013-04-10 | University Of Southern California | Verfahren zur Förderung der hämatopoietischen Zellproliferation und Differenzierung |
| AU6650098A (en) * | 1997-02-04 | 1998-08-25 | University Of Southern California | Method for accelerating healing of thermal injuries |
| US6197751B1 (en) | 1997-11-10 | 2001-03-06 | The United States Of America As Represented By The Department Of Health And Human Services | Thymosin α1 promotes tissue repair, angiogenesis and cell migration |
| US6248587B1 (en) | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
| AU1706399A (en) * | 1997-11-26 | 1999-06-15 | University Of Southern California | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| AU755225B2 (en) | 1997-12-12 | 2002-12-05 | University Of Southern California | Wound healing compositions |
| WO1999040106A2 (en) * | 1998-02-09 | 1999-08-12 | University Of Southern California | Use of angiotensin analogues for promoting erythropoiesis |
| US7173011B2 (en) | 2000-11-20 | 2007-02-06 | University Of Southern California | Radiation therapy methods |
| US6455500B1 (en) | 1998-03-10 | 2002-09-24 | University Of Southern California | Radiation therapy methods |
| AU3077299A (en) | 1998-03-11 | 1999-09-27 | University Of Southern California | Method of promoting production of living tissue equivalents |
| AU752041B2 (en) * | 1998-04-09 | 2002-09-05 | University Of Southern California | Methods for treatment and prevention of infections |
| US6762167B1 (en) | 1998-05-11 | 2004-07-13 | University Of Southern California | Methods for treating a patient undergoing chemotherapy |
| US6475988B1 (en) | 1998-05-11 | 2002-11-05 | University Of Southern California | Methods to increase white blood cell survival after chemotherapy |
| US6916783B2 (en) | 1998-07-13 | 2005-07-12 | University Of Southern California | Methods for accelerating bone and cartilage growth and repair |
| JP3686335B2 (ja) | 1998-07-13 | 2005-08-24 | ユニヴァースティ オブ サザーン カリフォルニア | 骨および軟骨成長と修復を促進する方法 |
| AU755943B2 (en) * | 1998-08-13 | 2003-01-02 | University Of Southern California | Methods to increase blood flow to ischemic tissue |
| PT1035133E (pt) | 1999-02-17 | 2005-05-31 | Pfizer Prod Inc | Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune |
| US6730775B1 (en) | 1999-03-23 | 2004-05-04 | University Of Southern California | Methods for limiting scar and adhesion formation |
| US7338938B2 (en) | 1999-05-10 | 2008-03-04 | University Of Southern California | Methods for treating a patient undergoing chemotherapy |
| US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| US6747008B1 (en) | 2000-06-19 | 2004-06-08 | University Of Southern California | Methods for treating and preventing alopecia |
| ATE474572T1 (de) * | 2000-11-30 | 2010-08-15 | Novodermix Internat Ltd | Heilung von wunden |
| WO2002087504A2 (en) * | 2001-05-01 | 2002-11-07 | University Of Southern California | Methods for inhibiting tumor cell proliferation |
| WO2009033820A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| RU2010113992A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение урокортина и кортиколиберина в качестве терапевтических средств |
| CA2699100A1 (en) * | 2007-09-11 | 2009-04-02 | Dorian Bevec | Use of a peptide as a therapeutic agent |
| EP2197463A2 (de) * | 2007-09-11 | 2010-06-23 | Mondobiotech Laboratories AG | Verwendung von rgdspasskp und optional angiotensin-ii als therapeutische mittel zur behandlung von z.b. infektionen mit s. pneumoniae |
| CA2699177A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| WO2009114461A2 (en) * | 2008-03-10 | 2009-09-17 | University Of Southern California | Angiotensin (1-7) dosage forms and uses thereof |
| JP5647146B2 (ja) | 2008-12-29 | 2014-12-24 | トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． | β−アレスチンエフェクターおよび組成物およびその使用方法 |
| MX2012010783A (es) | 2011-02-02 | 2012-11-23 | Univ Southern California | Metodos para tratar ulceras del pie diabetico. |
| EP2809337A4 (de) | 2012-01-31 | 2016-05-11 | Trevena Inc | Ss-arrestineffektoren und zusammensetzungen und anwendungsverfahren dafür |
| US8557958B1 (en) | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| US8633158B1 (en) | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| WO2015002903A1 (en) | 2013-07-03 | 2015-01-08 | Arizona Board Of Regents For The University Of Arizona | Method for treating cognitive dysfunction |
| JP2017506235A (ja) | 2014-02-07 | 2017-03-02 | トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． | ベータ−アレスチンエフェクターの結晶性および非晶質形態 |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| CA2948858A1 (en) | 2014-05-19 | 2015-11-26 | Trevena, Inc. | Synthesis of beta-arrestin effectors |
| US10183055B2 (en) | 2014-07-21 | 2019-01-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications |
| JP6666899B2 (ja) | 2014-07-21 | 2020-03-18 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニヴァーシティー オブ アリゾナ | Ａｎｇ−（１−７）誘導体オリゴペプチド、ならびにそれを使用および作製するための方法 |
| JP2018530590A (ja) * | 2015-10-14 | 2018-10-18 | タリックス ファーマシューティカルズ リミテッド | 表皮水疱症の処置のための方法及び組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3886134A (en) * | 1970-03-09 | 1975-05-27 | Morton Norwich Products Inc | Analogues of angiotensin II |
| US5015629A (en) * | 1989-06-26 | 1991-05-14 | University Of Southern California | Tissue repair |
-
1994
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-19 EP EP94928150A patent/EP0730465B1/de not_active Expired - Lifetime
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en not_active Ceased
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0730465T3 (da) | 2002-04-08 |
| WO1995008337A1 (en) | 1995-03-30 |
| US5629292A (en) | 1997-05-13 |
| TW311088B (de) | 1997-07-21 |
| AU706333B2 (en) | 1999-06-17 |
| EP0730465A1 (de) | 1996-09-11 |
| ES2168312T3 (es) | 2002-06-16 |
| EP0730465B1 (de) | 2001-12-12 |
| EP0730465A4 (de) | 1997-11-12 |
| AU7730294A (en) | 1995-04-10 |
| DE69429450T2 (de) | 2002-07-25 |
| CA2172493C (en) | 2003-09-16 |
| DE69429450D1 (de) | 2002-01-24 |
| JPH09502977A (ja) | 1997-03-25 |
| PT730465E (pt) | 2002-06-28 |
| CA2172493A1 (en) | 1995-03-30 |
| ZA947338B (en) | 1995-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE210677T1 (de) | Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung | |
| MX9703609A (es) | Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido. | |
| DE69435301D1 (de) | Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung | |
| ATE309775T1 (de) | Die verwendung von prostaglandin f analoga zur herstellung von zusammensetzungen für die behandlung von haarausfall. | |
| ATE393831T1 (de) | Zusammensetzung zur in vivo erzeugung von therapeutischen produkten | |
| DE69430440D1 (de) | Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten | |
| DE69230344D1 (de) | Zusammensetzungen und methoden zur wundbehandlung | |
| NO971568L (no) | Analoger av keratinocyttvekstfaktor | |
| ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
| ATE268782T1 (de) | Zusammensetzungen zur wundheilung | |
| ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
| AR018357A1 (es) | Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos | |
| ATE169445T1 (de) | Verwendung von gelformulierungen als beizmittel | |
| DE69535976D1 (de) | Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor | |
| DE69510775D1 (de) | Methoden zur verwendung von cyclischenpolyanionischen polyderivatenzur kontrolle von hautfalten | |
| IT1247945B (it) | Agente avente attivita' batteriostatica e battericida | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
| NO2019032I1 (no) | Treosulfan | |
| BR9611472A (pt) | Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios | |
| DK0613368T3 (da) | Hudregenererende kosmetisk sammensætning | |
| MX9709983A (es) | El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos. | |
| DE69931148D1 (de) | Behandlung von hiv infektionen | |
| ES2065308T1 (es) | Producto para el moldeado permanente del cabello y nuevos esteres de acido 2-hidroxi-3-mercaptopropionico reductores de la queratina capilar. | |
| EA199800953A1 (ru) | Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |